Emerging Trends in Dental Biomaterials Market Revenue

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.

Market Dynamics

+ Drivers

+ Increasing Penetration of Dental Implants

+ Increasing Prevalence of Dental Disorders

+ Rising Geriatric Population

+ Growing Dental Tourism in Developing Countries

+ Increasing Disposable Income in Developing Countries

Request for Free Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556

The market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of Dental Implants and the wide applications of metallic biomaterials in dentistry.

The market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.

The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals, Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).

Straumann is among the leading players in the dentistry industry. It is a global provider of dental products utilized in implants products, and oral tissue generation therapy. The company has a strong brand value and an established geographical presence. In 2017, Straumann reported an increase of 21% in its revenue, compared to 2016. The company is expected to grow further in the coming years due to its increasing focus on countries such as China, India, Argentina, Chile, and Colombia. Straumann significantly invests in R&D, sales, and marketing activities to drive innovation and to capture the growth potential in underpenetrated markets. In order to increase its customer base and maintain its position in the market, the company focuses on various growth strategies such as acquisitions, agreements, and product launches.

Recent Developments

• In 2018, The Straumann Group acquired a 30% stake in its biomaterials partner, Botiss medical AG, for an undisclosed sum. This acquisition enables Straumann to expand its dental biomaterials portfolio.
• In 2018, Henry Schein, Inc. acquired Intra-Lock (Spain), a provider of dental restoration solutions. This will enhance its position in the premium implant segment
• In 2018, Carpenter Technology Corporation announced the expansion of its Emerging Technology Center in the Alabama Campus (US).
• In 2017, Geistlich Pharma opened its tenth subsidiary in India. This marked Geistlich’s entry into a potentially interesting market for regenerative dentistry.